buprenorphine hydrochloride
buprenorphine hydrochloride is listed in the FDA National Drug Code directory with 19 NDC codes, marketed under brand names including buprenorphine hydrochloride, BELBUCA. Available dosage forms: tablet, film, soluble.
Drug Details
- Generic Name
- buprenorphine hydrochloride
- Brand Names
- buprenorphine hydrochloride, BELBUCA
- Application Number
- ANDA090279
- Sponsor
- Advagen Pharma Ltd
- NDC Codes
- 19
- Dosage Forms
- TABLET, FILM, SOLUBLE
- Routes
- SUBLINGUAL, BUCCAL
- Active Ingredients
- BUPRENORPHINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablets contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of opioid dependence and is preferred for induction. ( 1 ) Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support ( 1 ).